Skip to content

DEVA PHARMA

Active Risk: not assessed Private limited companyfounded 2012active for 14 yearsRidder de Ghellinckstraat 28, 8710 WielsbekeKBO/BCE: BE 0847.315.091

Board

1 director, last change in 2024
Director (not named in the articles)
appointed by deed of 12-02-2024 term without a fixed end
earlier manager, until 12-02-2024
listed in the 2025 annual accounts, filed on 29-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder. Hij kan bijzondere machten…”
deed of 12-02-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Muriel DEBEUCKELAERE
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • Muriel DEBEUCKELAERE
    • Director (not named in the articles), since before 31-12-2021
    • Manager, until 12-02-2024

Control

Capital

Contribution
€12,400
Source
2025 annual accounts

Articles of association

deed of 12-02-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Meerderheid aanwezig, alle_handelingen_nodig_of_nuttig_voor_voorwerp_behalve_wet_of_statuten_aan_AV”
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Helft overdrager,helft kopers naar evenredigheid van verworven aandelen, instemming van alle aandeelhouders op straffe van nietigheid”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June at 14:00

Next steps